Clinical • Enrollment change • Trial completion date • Trial termination • Trial primary completion date • PD(L)-1 Biomarker • IO biomarker
|
CD8 (cluster of differentiation 8) • MUC16 (Mucin 16, Cell Surface Associated) • CD14 (CD14 Molecule) • ITGAM (Integrin, alpha M)
|
ITGAM expression
|
Tecentriq (atezolizumab) • RG6146